Home › Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic Analyzers in Canada
 

Keywords :   


Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic Analyzers in Canada

2013-05-20 06:00:00| Industrial Newsroom - All News for Today

CARLSBAD, Calif. -- Life Technologies Corporation (NASDAQ:LIFE) today announced that its Applied Biosystems&trade; 3500 Dx /3500 xL Dx Genetic Analyzers CS2 have been approved by Health Canada for diagnostic use. The development marks a major extension of Life Technologies' capabilities to serve the clinical end market in North America with Sanger-based solutions.<br /> <br /> The Applied Biosystems&trade; 3500 Dx Series Genetic Analyzers deliver high quality performance, higher throughput and ...This story is related to the following:Test and Measuring InstrumentsSearch for suppliers of: Diagnostic Instruments |

Tags: life canada series technologies

Category:Industrial Goods and Services

Latest from this category

All news
01.10Boosting Membership Value
Industrial Goods and Services »
10.10EU delays introduction of border check system again
10.10Atlantic Tropical Weather Outlook
10.10Post-Tropical Cyclone Milton Public Advisory Number 22A
10.10Summary for Post-Tropical Cyclone Milton (AT4/AL142024)
10.10Eastern North Pacific Tropical Weather Outlook
10.10Hurricane Milton Graphics
10.10Meat Institute says USDA over-regulating beef, cattle markets
10.10BASF Completes Capability Upgrades for Superabsorbent Polymers in North America
More »